The global immunology market involves developing and providing monoclonal antibodies, cytokines, stem cell therapies, and other immunotherapeutic drugs for treating various diseases. Immunotherapies enhance the body's natural defenses to fight cancer, autoimmune disorders, and infectious diseases. Monoclonal antibodies are predominantly used immunotherapies that can selectively target specific...
Immune Checkpoint InhibitorsImmune checkpoint inhibitors work by releasing the brakes on immune system T cells to enhance their ability to recognize and destroy cancer cells. Checkpoints like Programmed cell death protein 1 (PD-1) and Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) are normally involved in regulating the immune response but can be exploited by cancers to evade immune...
In the fight against cancer, the Peptide Cancer Vaccine Market shines as a beacon of hope. These innovative vaccines hold the promise of more effective and targeted cancer treatments. By harnessing the power of the immune system, peptide cancer vaccines offer a safer and personalized approach to combating cancer. As research and development efforts intensify, the Peptide Cancer Vaccine...
Cancer immunotherapy is transforming the field of oncology by utilizing the body's immune system to fight cancer. Unlike traditional treatments that directly target cancer cells, immunotherapy empowers the immune system to recognize and destroy cancer cells more effectively.
It can be used as a standalone treatment or in combination with other therapies. Immune checkpoint inhibitors, CAR-T...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian